IGF2BP2 and cancer: IGF2BP2 expression was significantly reduced in ACC, BRCA and KIRC cancer samples, while it was significantly upregulated in COAD, ESCA, GBM, HNSC, LIHC, LUSC, OV, PAAD, READ, SKCM, STAD, TGCT and UCS cancer samples (Figure 3G).